Home » Pfizer Sees Harvard Collaboration as Spark for New Drugs
Pfizer Sees Harvard Collaboration as Spark for New Drugs
When Hal Dvorak, a Harvard scientist whose ideas helped spur the advance of targeted cancer drugs, sought a partner recently to help him develop new treatments, he only had to walk two blocks to find one.
Bloomberg
Bloomberg
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May